Login Register Cart 0
Generic placeholder image

Current Pediatric Reviews

Editor-in-Chief

ISSN (Print): 1573-3963
ISSN (Online): 1875-6336

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Review on Advances in Pediatric Endoscopy in the Management of Inflammatory Bowel Disease

In Press, (this is not the final "Version of Record"). Available online 23 January, 2024
Author(s): Sara Isoldi*, Saverio Mallardo, Paolo Quitadamo, Beatrice Leter and Salvatore Cucchiara
Published on: 23 January, 2024

DOI: 10.2174/0115733963268547231128101929

Price: $95

Abstract

Over the past decades, an increased importance has been given to gastrointestinal (GI) endoscopy in the management of children with inflammatory bowel diseases (IBD), considering that mucosal healing has been recognized as the optimal endpoint in the treat-to-target paradigm. The recent advances in technology and anesthesia have facilitated the comprehensive evaluation of the GI tract. In this review, we will discuss the role of ileocolonoscopy, upper GI endoscopy, and device-assisted enteroscopy in the work-up and management of pediatric Crohn’s disease (CD) and ulcerative colitis, with particular attention on non-invasive endoscopic techniques, such as wireless capsule endoscopy. We will also analyze the most commonly used endoscopic scoring systems, including small bowel scoring systems and endoscopic recurrence grading of neo-terminal ileum CD. Moreover, we will focus on the endoscopic management of complications, such as strictures, that commonly require surgery. Lastly, we will discuss cancer surveillance in children with IBD, with particular consideration of the role of high-definition endoscopic equipment and chromoendoscopy in dysplasia detection rates.

[1]
West CE, Renz H, Jenmalm MC, et al. The gut microbiota and inflammatory noncommunicable diseases: Associations and potentials for gut microbiota therapies. J Allergy Clin Immunol 2015; 135(1): 3-13.
[http://dx.doi.org/10.1016/j.jaci.2014.11.012] [PMID: 25567038]
[2]
Oliva S, Thomson M, de Ridder L, et al. Endoscopy in pediatric inflammatory bowel disease: A position paper on behalf of the porto IBD group of the european society for pediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr 2018; 67(3): 414-30.
[http://dx.doi.org/10.1097/MPG.0000000000002092] [PMID: 30130311]
[3]
Mosli MH, Zou G, Garg SK, et al. C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: A systematic review and meta-analysis. Am J Gastroenterol 2015; 110(6): 802-19.
[http://dx.doi.org/10.1038/ajg.2015.120] [PMID: 25964225]
[4]
Rokkas T, Portincasa P, Koutroubakis IE . Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis. J Gastrointestin Liver Dis 2018; 27(3): 299-306.
[http://dx.doi.org/10.15403/jgld.2014.1121.273.pti] [PMID: 30240474]
[5]
Holtman GA, Lisman-van Leeuwen Y, Reitsma JB, Berger MY. Noninvasive tests for inflammatory bowel disease: A meta-analysis. Pediatrics 2016; 137(1): e20152126.
[http://dx.doi.org/10.1542/peds.2015-2126] [PMID: 26681783]
[6]
Kawada PS, O’Loughlin EV, Stormon MO, Dutt S, Lee CH, Gaskin KJ. Are we overdoing pediatric lower gastrointestinal endoscopy? J Pediatr Gastroenterol Nutr 2017; 64(6): 898-902.
[http://dx.doi.org/10.1097/MPG.0000000000001192] [PMID: 26960173]
[7]
Thomson M, Eltumi M, Singh C, et al. Sub-10-minute high-quality diagnostic colonoscopy with terminal ileum intubation in children is feasible and safe. J Pediatr Gastroenterol Nutr 2019; 69(1): 6-12.
[http://dx.doi.org/10.1097/MPG.0000000000002326] [PMID: 30889130]
[8]
Williams CB, Laage NJ, Campbell CA, et al. Total colonoscopy in children. Arch Dis Child 1982; 57(1): 49-53.
[PMID: 7065694]
[9]
Thakkar K, Holub JL, Gilger MA, et al. Quality indicators for pediatric colonoscopy: Results from a multicenter consortium. Gastrointest Endosc 2016; 83(3): 533-41.
[http://dx.doi.org/10.1016/j.gie.2015.06.028] [PMID: 26253014]
[10]
Abdul Aziz D, Moin M, Majeed A, Sadiq K, Billoo AG. Paediatric inflammatory bowel disease: Clinical presentation and disease location. Pak J Med Sci 2017; 33(4): 793-7.
[http://dx.doi.org/10.12669/pjms.334.12926] [PMID: 29067041]
[11]
Shaoul R, Karban A, Reif S, et al. Disease behavior in children with Crohn’s disease: The effect of disease duration, ethnicity, genotype, and phenotype. Dig Dis Sci 2009; 54(1): 142-50.
[http://dx.doi.org/10.1007/s10620-008-0326-7] [PMID: 18594982]
[12]
Bakman Y, Katz J, Shepela C. Clinical significance of isolated peri-appendiceal lesions in patients with left sided ulcerative colitis. Gastroenterol Res 2011; 4(2): 58-63.
[http://dx.doi.org/10.4021/gr302w] [PMID: 27942315]
[13]
D’Haens G, Geboes K, Peeters M, Baert F, Ectors N, Rutgeerts P. Patchy cecal inflammation associated with distal ulcerative colitis: A prospective endoscopic study. Am J Gastroenterol 1997; 92(8): 1275-9.
[PMID: 9260788]
[14]
Levine A, Koletzko S, Turner D, et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr 2014; 58(6): 795-806.
[http://dx.doi.org/10.1097/MPG.0000000000000239] [PMID: 24231644]
[15]
Auvin S, Molinié F, Gower-Rousseau C, et al. Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999). J Pediatr Gastroenterol Nutr 2005; 41(1): 49-55.
[http://dx.doi.org/10.1097/01.MPG.0000162479.74277.86] [PMID: 15990630]
[16]
Castellaneta SP, Afzal NA, Greenberg M, et al. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2004; 39(3): 257-61.
[http://dx.doi.org/10.1097/00005176-200409000-00006] [PMID: 15319625]
[17]
Lemberg DA, Clarkson CM, Bohane TD, Day AS. Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease. J Gastroenterol Hepatol 2005; 20(11): 1696-700.
[http://dx.doi.org/10.1111/j.1440-1746.2005.03954.x] [PMID: 16246188]
[18]
Kundhal PS, Stormon MO, Zachos M, Critch JN, Cutz E, Griffiths AM. Gastral antral biopsy in the differentiation of pediatric colitides. Am J Gastroenterol 2003; 98(3): 557-61.
[http://dx.doi.org/10.1111/j.1572-0241.2003.07354.x] [PMID: 12650787]
[19]
Hummel TZ, ten Kate FJW, Reitsma JB, Benninga MA, Kindermann A. Additional value of upper GI tract endoscopy in the diagnostic assessment of childhood IBD. J Pediatr Gastroenterol Nutr 2012; 54(6): 753-7.
[http://dx.doi.org/10.1097/MPG.0b013e318243e3e3] [PMID: 22584746]
[20]
Kovacs M, Muller KE, Arato A, et al. Diagnostic yield of upper endoscopy in paediatric patients with Crohn’s disease and ulcerative colitis. Subanalysis of the HUPIR registry. J Crohn’s Colitis 2012; 6(1): 86-94.
[http://dx.doi.org/10.1016/j.crohns.2011.07.008] [PMID: 22261532]
[21]
Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, et al. ECCO-ESGAR guideline for diagnostic assessment in ibd part 1: Initial diagnosis, monitoring of known ibd, detection of complications J Crohns Colitis 2019; 13(2): 144-64.
[http://dx.doi.org/10.1093/ecco-jcc/jjy113]
[22]
Haskell H, Andrews CW Jr, Reddy SI, et al. Pathologic features and clinical significance of “backwash” ileitis in ulcerative colitis. Am J Surg Pathol 2005; 29(11): 1472-81.
[http://dx.doi.org/10.1097/01.pas.0000176435.19197.88] [PMID: 16224214]
[23]
Prenzel F, Uhlig HH. Frequency of indeterminate colitis in children and adults with IBD — a metaanalysis. J Crohn’s Colitis 2009; 3(4): 277-81.
[http://dx.doi.org/10.1016/j.crohns.2009.07.001] [PMID: 21172287]
[24]
Thomson M, Tringali A, Dumonceau JM, et al. Paediatric gastrointestinal endoscopy: European society for paediatric gastroenterology hepatology and nutrition and european society of gastrointestinal endoscopy guidelines. J Pediatr Gastroenterol Nutr 2017; 64(1): 133-53.
[http://dx.doi.org/10.1097/MPG.0000000000001408] [PMID: 27622898]
[25]
Halligan S, Nicholls S, Bartram CI, Walker-Smith JA. The distribution of small bowel Crohn’s disease in children compared to adults. Clin Radiol 1994; 49(5): 314-6.
[http://dx.doi.org/10.1016/S0009-9260(05)81794-5] [PMID: 8013193]
[26]
Cuffari C, Dubinsky M, Darbari A, Sena L, Baldassano R. Crohn’s jejunoileitis: The pediatrician’s perspective on diagnosis and management. Inflamm Bowel Dis 2005; 11(7): 696-704.
[http://dx.doi.org/10.1097/01.MIB.0000166933.74477.69] [PMID: 15973125]
[27]
Pimentel M, Chang M, Chow EJ, et al. Identification of a prodromal period in Crohn’s disease but not ulcerative colitis. Am J Gastroenterol 2000; 95(12): 3458-62.
[http://dx.doi.org/10.1111/j.1572-0241.2000.03361.x] [PMID: 11151877]
[28]
Fong SCM, Irving PM. Distinct management issues with Crohnʼs disease of the small intestine. Curr Opin Gastroenterol 2015; 31(2): 92-7.
[http://dx.doi.org/10.1097/MOG.0000000000000149] [PMID: 25594888]
[29]
Di Nardo G, de Ridder L, Oliva S, Casciani E, Escher JC, Cucchiara S. Enteroscopy in paediatric Crohn’s disease. Dig Liver Dis 2013; 45(5): 351-5.
[http://dx.doi.org/10.1016/j.dld.2012.07.020] [PMID: 22947488]
[30]
Axelrad JE, Olén O, Sachs MC, et al. Inflammatory bowel disease and risk of small bowel cancer: A binational population-based cohort study from Denmark and Sweden. Gut 2020; 70(2): gutjnl-2020-320945.
[http://dx.doi.org/10.1136/gutjnl-2020-320945] [PMID: 32474410]
[31]
Aloi M, Di Nardo G, Romano G, Casciani E, Civitelli F, Oliva S, et al. Magnetic resonance enterography, small-intestine contrast US, and capsule endoscopy to evaluate the small bowel in pediatric Crohn's disease: A prospective, blinded, comparison study. Gastrointest Endosc 2015; 81(2): 420-7.
[http://dx.doi.org/10.1016/j.gie.2014.07.009]
[32]
Panés J, Bouzas R, Chaparro M, et al. Systematic review: The use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther 2011; 34(2): 125-45.
[http://dx.doi.org/10.1111/j.1365-2036.2011.04710.x] [PMID: 21615440]
[33]
Jensen MD, Nathan T, Rafaelsen SR, Kjeldsen J. Diagnostic accuracy of capsule endoscopy for small bowel Crohn’s disease is superior to that of MR enterography or CT enterography. Clin Gastroenterol Hepatol 2011; 9(2): 124-129.e1.
[http://dx.doi.org/10.1016/j.cgh.2010.10.019] [PMID: 21056692]
[34]
González-Suárez B, Rodriguez S, Ricart E, et al. Comparison of capsule endoscopy and magnetic resonance enterography for the assessment of small bowel lesions in crohn’s disease. Inflamm Bowel Dis 2018; 24(4): 775-80.
[http://dx.doi.org/10.1093/ibd/izx107] [PMID: 29506048]
[35]
Choi M, Lim S, Choi MG, Shim KN, Lee SH. Effectiveness of capsule endoscopy compared with other diagnostic modalities in patients with small bowel crohn’s disease: A meta-analysis. Gut Liver 2017; 11(1): 62-72.
[http://dx.doi.org/10.5009/gnl16015] [PMID: 27728963]
[36]
Greener T, Klang E, Yablecovitch D, et al. The impact of magnetic resonance enterography and capsule endoscopy on the re-classification of disease in patients with known crohn’s disease: A prospective israeli ibd research nucleus (IIRN) study. J Crohn’s Colitis 2016; 10(5): 525-31.
[http://dx.doi.org/10.1093/ecco-jcc/jjw006] [PMID: 26748404]
[37]
Pennazio M, Spada C, Eliakim R, et al. Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European society of gastrointestinal endoscopy (ESGE) clinical guideline. Endoscopy 2015; 47(4): 352-86.
[http://dx.doi.org/10.1055/s-0034-1391855] [PMID: 25826168]
[38]
Fritscher-Ravens A, Scherbakov P, Bufler P, et al. The feasibility of wireless capsule endoscopy in detecting small intestinal pathology in children under the age of 8 years: A multicentre european study. Gut 2009; 58(11): 1467-72.
[http://dx.doi.org/10.1136/gut.2009.177774] [PMID: 19625281]
[39]
Barth BA, Donovan K, Fox VL. Endoscopic placement of the capsule endoscope in children. Gastrointest Endosc 2004; 60(5): 818-21.
[http://dx.doi.org/10.1016/S0016-5107(04)02052-8] [PMID: 15557968]
[40]
Viazis N, Sgouros S, Papaxoinis K, et al. Bowel preparation increases the diagnostic yield of capsule endoscopy: A prospective, randomized, controlled study. Gastrointest Endosc 2004; 60(4): 534-8.
[http://dx.doi.org/10.1016/S0016-5107(04)01879-6] [PMID: 15472674]
[41]
Lapalus MG, Soussan EB, Saurin JC, et al. Capsule endoscopy and bowel preparation with oral sodium phosphate: A prospective randomized controlled trial. Gastrointest Endosc 2008; 67(7): 1091-6.
[http://dx.doi.org/10.1016/j.gie.2007.11.053] [PMID: 18513551]
[42]
Park SC, Keum B, Seo YS, et al. Effect of bowel preparation with polyethylene glycol on quality of capsule endoscopy. Dig Dis Sci 2011; 56(6): 1769-75.
[http://dx.doi.org/10.1007/s10620-010-1500-2] [PMID: 21161380]
[43]
Niv Y. Efficiency of bowel preparation for capsule endoscopy examination: A meta-analysis. World J Gastroenterol 2008; 14(9): 1313-7.
[http://dx.doi.org/10.3748/wjg.14.1313] [PMID: 18322940]
[44]
Rokkas T, Papaxoinis K, Triantafyllou K, Pistiolas D, Ladas SD. Does purgative preparation influence the diagnostic yield of small bowel video capsule endoscopy?: A meta-analysis. Am J Gastroenterol 2009; 104(1): 219-27.
[http://dx.doi.org/10.1038/ajg.2008.63] [PMID: 19098872]
[45]
Kotwal VS, Attar BM, Gupta S, Agarwal R. Should bowel preparation, antifoaming agents, or prokinetics be used before video capsule endoscopy? A systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2014; 26(2): 137-45.
[http://dx.doi.org/10.1097/MEG.0b013e328365b9d4] [PMID: 24220156]
[46]
Wu S, Gao YJ, Ge ZZ. Optimal use of polyethylene glycol for preparation of small bowel video capsule endoscopy: A network meta-analysis. Curr Med Res Opin 2017; 33(6): 1149-54.
[http://dx.doi.org/10.1080/03007995.2017.1308922] [PMID: 28318326]
[47]
Oliva S, Cucchiara S, Spada C, et al. Small bowel cleansing for capsule endoscopy in paediatric patients: A prospective randomized single-blind study. Dig Liver Dis 2014; 46(1): 51-5.
[http://dx.doi.org/10.1016/j.dld.2013.08.130] [PMID: 24041737]
[48]
Friedlander JA, Liu QY, Sahn B, et al. NASPGHAN capsule endoscopy clinical report. J Pediatr Gastroenterol Nutr 2017; 64(3): 485-94.
[http://dx.doi.org/10.1097/MPG.0000000000001413] [PMID: 27642781]
[49]
Broide E, Shalem T, Richter V, Matalon S, Shirin H. The safety and feasibility of a new through-the-scope balloon-assisted enteroscopy in children. J Pediatr Gastroenterol Nutr 2020; 71(1): e6-e11.
[http://dx.doi.org/10.1097/MPG.0000000000002706] [PMID: 32187142]
[50]
Di Nardo G, Oliva S, Aloi M, et al. Usefulness of single-balloon enteroscopy in pediatric Crohn’s disease. Gastrointest Endosc 2012; 75(1): 80-6.
[http://dx.doi.org/10.1016/j.gie.2011.06.021] [PMID: 21855873]
[51]
de Ridder L, Mensink PBF, Lequin MH, et al. Single-balloon enteroscopy, magnetic resonance enterography, and abdominal US useful for evaluation of small-bowel disease in children with (suspected) Crohn’s disease. Gastrointest Endosc 2012; 75(1): 87-94.
[http://dx.doi.org/10.1016/j.gie.2011.07.036] [PMID: 21963066]
[52]
Urs AN, Martinelli M, Rao P, Thomson MA. Diagnostic and therapeutic utility of double-balloon enteroscopy in children. J Pediatr Gastroenterol Nutr 2014; 58(2): 204-12.
[http://dx.doi.org/10.1097/MPG.0000000000000192] [PMID: 24126830]
[53]
Uchida K, Yoshiyama S, Inoue M, et al. Double balloon enteroscopy for pediatric inflammatory bowel disease. Pediatr Int 2012; 54(6): 806-9.
[http://dx.doi.org/10.1111/j.1442-200X.2012.03661.x] [PMID: 22564182]
[54]
Oliva S, Cohen SA, Di Nardo G, Gualdi G, Cucchiara S, Casciani E. Capsule endoscopy in pediatrics: A 10-years journey. World J Gastroenterol 2014; 20(44): 16603-8.
[http://dx.doi.org/10.3748/wjg.v20.i44.16603] [PMID: 25469028]
[55]
Cohen SA, Klevens AI. Use of capsule endoscopy in diagnosis and management of pediatric patients, based on meta-analysis. Clin Gastroenterol Hepatol 2011; 9(6): 490-6.
[http://dx.doi.org/10.1016/j.cgh.2011.03.025] [PMID: 21440674]
[56]
Cohen SA, Ephrath H, Lewis JD, et al. Pediatric capsule endoscopy: Review of the small bowel and patency capsules. J Pediatr Gastroenterol Nutr 2012; 54(3): 409-13.
[http://dx.doi.org/10.1097/MPG.0b013e31822c81fd] [PMID: 21760541]
[57]
Neurath MF, Travis SPL. Mucosal healing in inflammatory bowel diseases: A systematic review. Gut 2012; 61(11): 1619-35.
[http://dx.doi.org/10.1136/gutjnl-2012-302830] [PMID: 22842618]
[58]
Walters TD, Kim MO, Denson LA, et al. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn’s disease. Gastroenterology 2014; 146(2): 383-91.
[http://dx.doi.org/10.1053/j.gastro.2013.10.027] [PMID: 24162032]
[59]
Grover Z, Burgess C, Muir R, Reilly C, Lewindon PJ. Early mucosal healing with exclusive enteral nutrition is associated with improved outcomes in newly diagnosed children with luminal crohn’s disease. J Crohn’s Colitis 2016; 10(10): 1159-64.
[http://dx.doi.org/10.1093/ecco-jcc/jjw075] [PMID: 26980840]
[60]
Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): Determining therapeutic goals for treat-to-target. Am J Gastroenterol 2015; 110(9): 1324-38.
[http://dx.doi.org/10.1038/ajg.2015.233] [PMID: 26303131]
[61]
Santha SL, Shankar PR, Pan A, Schoen B, Kugathasan S, Sauer CG. Mucosal healing in clinical practice. Inflamm Bowel Dis 2017; 23(8): 1447-53.
[http://dx.doi.org/10.1097/MIB.0000000000001176] [PMID: 28644180]
[62]
Turner D, Griffiths AM, Veerman G, et al. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab. Clin Gastroenterol Hepatol 2013; 11(11): 1460-5.
[http://dx.doi.org/10.1016/j.cgh.2013.04.049] [PMID: 23672831]
[63]
Hanai H, Takeuchi K, Iida T, et al. Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis. Dig Dis Sci 2004; 49(9): 1438-43.
[http://dx.doi.org/10.1023/B:DDAS.0000042243.47279.87] [PMID: 15481316]
[64]
Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med 2010; 362(15): 1383-95.
[http://dx.doi.org/10.1056/NEJMoa0904492] [PMID: 20393175]
[65]
Daperno M, Castiglione F, de Ridder L, et al. Results of the 2nd part Scientific Workshop of the ECCO (II): Measures and markers of prediction to achieve, detect, and monitor intestinal healing in Inflammatory Bowel Disease. J Crohn’s Colitis 2011; 5(5): 484-98.
[http://dx.doi.org/10.1016/j.crohns.2011.07.003] [PMID: 21939926]
[66]
Colombel JF, Sandborn WJ, Rutgeerts P, et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn’s disease: The CHARM trial. Gastroenterology 2007; 132(1): 52-65.
[http://dx.doi.org/10.1053/j.gastro.2006.11.041] [PMID: 17241859]
[67]
Kugathasan S, Denson LA, Walters TD, et al. Prediction of complicated disease course for children newly diagnosed with Crohn’s disease: A multicentre inception cohort study. Lancet 2017; 389(10080): 1710-8.
[http://dx.doi.org/10.1016/S0140-6736(17)30317-3] [PMID: 28259484]
[68]
Thakkar K, Lucia CJ, Ferry GD, et al. Repeat endoscopy affects patient management in pediatric inflammatory bowel disease. Am J Gastroenterol 2009; 104(3): 722-7.
[http://dx.doi.org/10.1038/ajg.2008.111] [PMID: 19209163]
[69]
Issa M, Vijayapal A, Graham MB, et al. Impact of clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007; 5(3): 345-51.
[http://dx.doi.org/10.1016/j.cgh.2006.12.028] [PMID: 17368234]
[70]
Rahier JF, Magro F, Abreu C, et al. Second european evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohn’s Colitis 2014; 8(6): 443-68.
[http://dx.doi.org/10.1016/j.crohns.2013.12.013] [PMID: 24613021]
[71]
Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2012; 107(10): 1474-82.
[http://dx.doi.org/10.1038/ajg.2012.260] [PMID: 22929759]
[72]
Stanisic V, Quigley EMM. The overlap between IBS and IBD – what is it and what does it mean? Expert Rev Gastroenterol Hepatol 2014; 8(2): 139-45.
[http://dx.doi.org/10.1586/17474124.2014.876361] [PMID: 24417262]
[73]
Shen B, Sanmiguel C, Bennett AE, et al. Irritable pouch syndrome is characterized by visceral hypersensitivity. Inflamm Bowel Dis 2011; 17(4): 994-1002.
[http://dx.doi.org/10.1002/ibd.21412] [PMID: 20684016]
[74]
Shen B, Achkar JP, Lashner BA, et al. Irritable pouch syndrome: A new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002; 97(4): 972-7.
[http://dx.doi.org/10.1111/j.1572-0241.2002.05617.x] [PMID: 12003434]
[75]
Bruining DH, Oliva S, Fleisher MR, Fischer M, Fletcher JG. Panenteric capsule endoscopy versus ileocolonoscopy plus magnetic resonance enterography in Crohn’s disease: a multicentre, prospective study. BMJ Open Gastroenterol 2020; 7(1): e000365.
[http://dx.doi.org/10.1136/bmjgast-2019-000365] [PMID: 32499275]
[76]
Cohen SA, Gold BD, Oliva S, et al. Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2014; 59(4): 516-21.
[http://dx.doi.org/10.1097/MPG.0000000000000449] [PMID: 24897165]
[77]
Oliva S, Aloi M, Viola F, et al. A treat to target strategy using panenteric capsule endoscopy in pediatric patients with crohn’s disease. Clin Gastroenterol Hepatol 2019; 17(10): 2060-2067.e1.
[http://dx.doi.org/10.1016/j.cgh.2018.10.015] [PMID: 30326301]
[78]
Colombel JF, Panaccione R, Bossuyt P, et al. Effect of tight control management on Crohn’s disease (CALM): A multicentre, randomised, controlled phase 3 trial. Lancet 2017; 390(10114): 2779-89.
[http://dx.doi.org/10.1016/S0140-6736(17)32641-7] [PMID: 29096949]
[79]
Fernandes SR, Rodrigues RV, Bernardo S, et al. Transmural healing is associated with improved long-term outcomes of patients with crohnʼs disease. Inflamm Bowel Dis 2017; 23(8): 1403-9.
[http://dx.doi.org/10.1097/MIB.0000000000001143] [PMID: 28498158]
[80]
Maconi G, Armuzzi A. Beyond remission and mucosal healing in Crohn’s disease. Exploring the deep with cross sectional imaging. Dig Liver Dis 2017; 49(5): 457-8.
[http://dx.doi.org/10.1016/j.dld.2017.04.009] [PMID: 28449813]
[81]
Paredes JM, Moreno N, Latorre P, et al. Clinical impact of sonographic transmural healing after anti-tnf antibody treatment in patients with crohn’s disease. Dig Dis Sci 2019; 64(9): 2600-6.
[http://dx.doi.org/10.1007/s10620-019-05567-w] [PMID: 30874986]
[82]
Sauer CG, Middleton JP, McCracken C, et al. Magnetic resonance enterography healing and magnetic resonance enterography remission predicts improved outcome in pediatric crohn disease. J Pediatr Gastroenterol Nutr 2016; 62(3): 378-83.
[http://dx.doi.org/10.1097/MPG.0000000000000976] [PMID: 26348683]
[83]
Cucchiara S, D’Arcangelo G, Isoldi S, Aloi M, Stronati L. Mucosal healing in Crohn’s disease: New insights. Expert Rev Gastroenterol Hepatol 2020; 14(5): 335-45.
[http://dx.doi.org/10.1080/17474124.2020.1759416] [PMID: 32315209]
[84]
De Cruz P, Kamm MA, Hamilton AL, et al. Crohn’s disease management after intestinal resection: A randomised trial. Lancet 2015; 385(9976): 1406-17.
[http://dx.doi.org/10.1016/S0140-6736(14)61908-5] [PMID: 25542620]
[85]
de Ridder L, Turner D, Wilson DC, et al. Malignancy and mortality in pediatric patients with inflammatory bowel disease: A multinational study from the porto pediatric IBD group. Inflamm Bowel Dis 2014; 20(2): 291-300.
[http://dx.doi.org/10.1097/01.MIB.0000439066.69340.3c] [PMID: 24374875]
[86]
Peneau A, Savoye G, Turck D, et al. Mortality and cancer in pediatric-onset inflammatory bowel disease: A population-based study. Am J Gastroenterol 2013; 108(10): 1647-53.
[http://dx.doi.org/10.1038/ajg.2013.242] [PMID: 23939626]
[87]
Hyams JS, Dubinsky MC, Baldassano RN, et al. Infliximab is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis in pediatric patients with inflammatory bowel disease. Gastroenterology 2017; 152(8): 1901-1914.e3.
[http://dx.doi.org/10.1053/j.gastro.2017.02.004] [PMID: 28193515]
[88]
Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323(18): 1228-33.
[http://dx.doi.org/10.1056/NEJM199011013231802] [PMID: 2215606]
[89]
Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 2001; 48(4): 526-35.
[http://dx.doi.org/10.1136/gut.48.4.526] [PMID: 11247898]
[90]
Lakatos L, Mester G, Erdelyi Z, et al. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: Results of a population-based study. Inflamm Bowel Dis 2006; 12(3): 205-11.
[http://dx.doi.org/10.1097/01.MIB.0000217770.21261.ce] [PMID: 16534422]
[91]
Kappelman MD, Farkas DK, Long MD, et al. Risk of cancer in patients with inflammatory bowel diseases: A nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol 2014; 12(2): 265-273.e1.
[http://dx.doi.org/10.1016/j.cgh.2013.03.034] [PMID: 23602821]
[92]
Jess T, Simonsen J, Jørgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology 2012; 143(2): 375-381.e1.
[http://dx.doi.org/10.1053/j.gastro.2012.04.016] [PMID: 22522090]
[93]
Nuako K, Ahlquist D, Mahoney D, Schaid D, Siems D, Lindor N. Familial predisposition for colorectal cancer in chronic ulcerative colitis: A case-control study. Gastroenterology 1998; 115(5): 1079-83.
[http://dx.doi.org/10.1016/S0016-5085(98)70077-0] [PMID: 9797361]
[94]
Itzkowitz SH, Present DH. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11(3): 314-21.
[http://dx.doi.org/10.1097/01.MIB.0000160811.76729.d5] [PMID: 15735438]
[95]
Efthymiou M, Allen PB, Taylor ACF, et al. Chromoendoscopy versus narrow band imaging for colonic surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2013; 19(10): 2132-8.
[http://dx.doi.org/10.1097/MIB.0b013e31829637b9] [PMID: 23899540]
[96]
Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 2015; 148(3): 639-651.e28.
[http://dx.doi.org/10.1053/j.gastro.2015.01.031] [PMID: 25702852]
[97]
Rispo A, Castiglione F, Staibano S, et al. Diagnostic accuracy of confocal laser endomicroscopy in diagnosing dysplasia in patients affected by long-standing ulcerative colitis. World J Gastrointest Endosc 2012; 4(9): 414-20.
[http://dx.doi.org/10.4253/wjge.v4.i9.414] [PMID: 23125900]
[98]
Khanna R, Bouguen G, Feagan BG, et al. A systematic review of measurement of endoscopic disease activity and mucosal healing in Crohn’s disease: recommendations for clinical trial design. Inflamm Bowel Dis 2014; 20(10): 1850-61.
[http://dx.doi.org/10.1097/MIB.0000000000000131] [PMID: 25029615]
[99]
Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn’s disease: a prospective multicentre study. Groupe d’Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989; 30(7): 983-9.
[http://dx.doi.org/10.1136/gut.30.7.983] [PMID: 2668130]
[100]
Modigliani R, Mary JY. Reproducibility of colonoscopic findings in Crohn’s disease: A prospective multicenter study of interobserver variation. Dig Dis Sci 1987; 32(12): 1370-9.
[http://dx.doi.org/10.1007/BF01296663] [PMID: 3319454]
[101]
Daperno M, D’Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc 2004; 60(4): 505-12.
[http://dx.doi.org/10.1016/S0016-5107(04)01878-4] [PMID: 15472670]
[102]
Sipponen T, Nuutinen H, Turunen U, Färkkilä M. Endoscopic evaluation of Crohn’s disease activity: Comparison of the CDEIS and the SES-CD. Inflamm Bowel Dis 2010; 16(12): 2131-6.
[http://dx.doi.org/10.1002/ibd.21300] [PMID: 20848462]
[103]
Khanna R, Zou G, D’Haens G, et al. Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn’s disease. Gut 2016; 65(7): 1119-25.
[http://dx.doi.org/10.1136/gutjnl-2014-308973] [PMID: 25935574]
[104]
Sostegni R, Daperno M, Scaglione N, Lavagna A, Rocca R, Pera A. Crohn’s disease: Monitoring disease activity. Aliment Pharmacol Ther 2003; 17(s2) (Suppl. 2): 11-7.
[http://dx.doi.org/10.1046/j.1365-2036.17.s2.17.x] [PMID: 12786607]
[105]
Ferrante M, Colombel JF, Sandborn WJ, et al. Validation of endoscopic activity scores in patients with Crohn’s disease based on a post hoc analysis of data from SONIC. Gastroenterology 2013; 145(5): 978-986.e5.
[http://dx.doi.org/10.1053/j.gastro.2013.08.010] [PMID: 23954314]
[106]
Vuitton L, Marteau P, Sandborn WJ, et al. IOIBD technical review on endoscopic indices for Crohn’s disease clinical trials. Gut 2016; 65(9): 1447-55.
[http://dx.doi.org/10.1136/gutjnl-2015-309903] [PMID: 26353983]
[107]
Rutgeerts P, Van Assche G, Sandborn WJ, et al. Adalimumab induces and maintains mucosal healing in patients with Crohn’s disease: Data from the EXTEND trial. Gastroenterology 2012; 142(5): 1102-1111.e2.
[http://dx.doi.org/10.1053/j.gastro.2012.01.035] [PMID: 22326435]
[108]
Klenske E, Bojarski C, Waldner M, Rath T, Neurath MF, Atreya R. Targeting mucosal healing in Crohn's disease: What the clinician needs to know. Therap Adv Gastroenterol 2019; 14: 12.
[http://dx.doi.org/10.1177/1756284819856865]
[109]
Ruemmele FM, Hyams JS, Otley A, et al. Outcome measures for clinical trials in paediatric IBD: An evidence-based, expert-driven practical statement paper of the paediatric ECCO committee. Gut 2015; 64(3): 438-46.
[http://dx.doi.org/10.1136/gutjnl-2014-307008] [PMID: 24821616]
[110]
Cotter J, Dias de Castro F, Magalhães J, Moreira M, Rosa B. Validation of the lewis score for the evaluation of small-bowel crohn’s disease activity. Endoscopy 2015; 47(4): 334.
[http://dx.doi.org/10.1055/s-0034-1391621] [PMID: 25412092]
[111]
Rosa B, Moreira MJ, Rebelo A, Cotter J. Lewis score: A useful clinical tool for patients with suspected crohn’s disease submitted to capsule endoscopy. J Crohn’s Colitis 2012; 6(6): 692-7.
[http://dx.doi.org/10.1016/j.crohns.2011.12.002] [PMID: 22398099]
[112]
Niv Y, Ilani S, Levi Z, et al. Validation of the capsule endoscopy crohn’s disease activity index (cecdai or niv score): A multicenter prospective study. Endoscopy 2012; 44(1): 21-6.
[http://dx.doi.org/10.1055/s-0031-1291385] [PMID: 22125196]
[113]
Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn’s disease. Gastroenterology 1990; 99(4): 956-63.
[http://dx.doi.org/10.1016/0016-5085(90)90613-6] [PMID: 2394349]
[114]
Daperno M, Comberlato M, Bossa F, et al. Inter-observer agreement in endoscopic scoring systems: Preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD). Dig Liver Dis 2014; 46(11): 969-73.
[http://dx.doi.org/10.1016/j.dld.2014.07.010] [PMID: 25154049]
[115]
Mohammed Vashist N, Samaan M, Mosli MH, et al. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis. Cochrane Libr 2018; 1(1): CD011450.
[http://dx.doi.org/10.1002/14651858.CD011450.pub2] [PMID: 29338066]
[116]
Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987; 317(26): 1625-9.
[http://dx.doi.org/10.1056/NEJM198712243172603] [PMID: 3317057]
[117]
Samaan MA, Mosli MH, Sandborn WJ, et al. A systematic review of the measurement of endoscopic healing in ulcerative colitis clinical trials: Recommendations and implications for future research. Inflamm Bowel Dis 2014; 20(8): 1465-71.
[http://dx.doi.org/10.1097/MIB.0000000000000046] [PMID: 24831558]
[118]
Pagnini C, Menasci F, Desideri F, Corleto VD, Delle Fave G, Di Giulio E. Endoscopic scores for inflammatory bowel disease in the era of ‘mucosal healing’: Old problem, new perspectives. Dig Liver Dis 2016; 48(7): 703-8.
[http://dx.doi.org/10.1016/j.dld.2016.03.006] [PMID: 27050942]
[119]
Travis SPL, Schnell D, Krzeski P, et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: The ulcerative colitis endoscopic index of severity (UCEIS). Gut 2012; 61(4): 535-42.
[http://dx.doi.org/10.1136/gutjnl-2011-300486] [PMID: 21997563]
[120]
Samuel S, Bruining DH, Loftus EV Jr, et al. Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures. Clin Gastroenterol Hepatol 2013; 11(1): 49-54.e1.
[http://dx.doi.org/10.1016/j.cgh.2012.08.003] [PMID: 22902762]
[121]
Lobatón T, Bessissow T, De Hertogh G, et al. The modified mayo endoscopic score (MMES): A new index for the assessment of extension and severity of endoscopic activity in ulcerative colitis patients. J Crohn’s Colitis 2015; 9(10): 846-52.
[http://dx.doi.org/10.1093/ecco-jcc/jjv111] [PMID: 26116558]
[122]
Rieder F, Latella G, Magro F, et al. European crohn’s and colitis organisation topical review on prediction, diagnosis and management of fibrostenosing crohn’s disease. J Crohn’s Colitis 2016; 10(8): 873-85.
[http://dx.doi.org/10.1093/ecco-jcc/jjw055] [PMID: 26928961]
[123]
Ledder O, Viala J, Serban DE, et al. Endoscopic balloon dilatation in pediatric crohn disease: An IBD porto group study. J Pediatr Gastroenterol Nutr 2023; 77(1): 62-9.
[http://dx.doi.org/10.1097/MPG.0000000000003783] [PMID: 36976584]
[124]
McSorley B, Cina RA, Jump C, Palmadottir J, Quiros JA. Endoscopic balloon dilation for management of stricturing Crohn’s disease in children. World J Gastrointest Endosc 2021; 13(9): 382-90.
[http://dx.doi.org/10.4253/wjge.v13.i9.382] [PMID: 34630888]
[125]
de’Angelis N, Carra MC, Borrelli O, et al. Short- and long-term efficacy of endoscopic balloon dilation in Crohn’s disease strictures. World J Gastroenterol 2013; 19(17): 2660-7.
[http://dx.doi.org/10.3748/wjg.v19.i17.2660] [PMID: 23674873]
[126]
Nanda K, Courtney W, Keegan D, et al. Prolonged avoidance of repeat surgery with endoscopic balloon dilatation of anastomotic strictures in Crohn’s disease. J Crohn’s Colitis 2013; 7(6): 474-80.
[http://dx.doi.org/10.1016/j.crohns.2012.07.019] [PMID: 22898397]
[127]
Endo K, Takahashi S, Shiga H, Kakuta Y, Kinouchi Y, Shimosegawa T. Short and long-term outcomes of endoscopic balloon dilatation for Crohn’s disease strictures. World J Gastroenterol 2013; 19(1): 86-91.
[http://dx.doi.org/10.3748/wjg.v19.i1.86] [PMID: 23326167]
[128]
Hagel AF, Hahn A, Dauth W, et al. Outcome and complications of endoscopic balloon dilatations in various types of ileocaecal and colonic stenosis in patients with Crohn’s disease. Surg Endosc 2014; 28(10): 2966-72.
[http://dx.doi.org/10.1007/s00464-014-3559-x] [PMID: 24853850]
[129]
Bhalme M, Sarkar S, Lal S, Bodger K, Baker R, Willert RP. Endoscopic balloon dilatation of Crohn’s disease strictures: Results from a large United kingdom series. Inflamm Bowel Dis 2014; 20(2): 265-70.
[http://dx.doi.org/10.1097/01.MIB.0000439067.76964.53] [PMID: 24374876]
[130]
Di Nardo G, Oliva S, Passariello M, et al. Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn’s disease with stricture: A prospective, randomized, double-blind, controlled trial. Gastrointest Endosc 2010; 72(6): 1201-8.
[http://dx.doi.org/10.1016/j.gie.2010.08.003] [PMID: 20951986]
[131]
East JE, Brooker JC, Rutter MD, Saunders BP. A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn’s strictures. Clin Gastroenterol Hepatol 2007; 5(9): 1065-9.
[http://dx.doi.org/10.1016/j.cgh.2007.04.013] [PMID: 17627903]
[132]
Brooker JC, Beckett CG, Saunders BP, Benson MJ. Long-acting steroid injection after endoscopic dilation of anastomotic Crohn’s strictures may improve the outcome: A retrospective case series. Endoscopy 2003; 35(4): 333-7.
[http://dx.doi.org/10.1055/s-2003-38145] [PMID: 12664391]
[133]
Lavy A. Triamcinolone improves outcome in crohn’s disease strictures. Dis Colon Rectum 1997; 40(2): 184-6.
[http://dx.doi.org/10.1007/BF02054985] [PMID: 9075754]
[134]
Van Assche G. Intramural steroid injection and endoscopic dilation for Crohn’s disease. Clin Gastroenterol Hepatol 2007; 5(9): 1027-8.
[http://dx.doi.org/10.1016/j.cgh.2007.07.003] [PMID: 17825771]
[135]
Swaminath A, Lichtiger S. Dilation of colonic strictures by intralesional injection of infliximab in patients with Crohnʼs colitis. Inflamm Bowel Dis 2008; 14(2): 213-6.
[http://dx.doi.org/10.1002/ibd.20318] [PMID: 18022870]
[136]
Hendel J, Karstensen JG, Vilmann P. Serial intralesional injections of infliximab in small bowel Crohn’s strictures are feasible and might lower inflammation. United European Gastroenterol J 2014; 2(5): 406-12.
[http://dx.doi.org/10.1177/2050640614547805] [PMID: 25360319]
[137]
Rosseneu S, Afzal N, Yerushalmi B, et al. Topical application of mitomycin-C in oesophageal strictures. J Pediatr Gastroenterol Nutr 2007; 44(3): 336-41.
[http://dx.doi.org/10.1097/MPG.0b013e31802c6e45] [PMID: 17325554]
[138]
Ledder O, Homan M, Furlano R, et al. Approach to endoscopic balloon dilatation in pediatric stricturing crohn disease: A position paper of the endoscopy special interest group of ESPGHAN. J Pediatr Gastroenterol Nutr 2023; 76(6): 799-806.
[http://dx.doi.org/10.1097/MPG.0000000000003752] [PMID: 36867853]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy